This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

39/100

✓ Peer-reviewed alzhub usefulness score 39 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

Fourteen studies met eligibility criteria, covering populations from healthy controls to individuals with subjective cognitive decline, MCI, AD, and other dementias. MEG systems varied, with most studies employing 306-channel whole-head systems. ML algorithms ranged from traditional approaches, such as support vector machines and random forests, to deep learning architectures, including convolutional neural networks. Reported classification accuracies ranged from moderate (~60%) to high, with several studies achieving over 80% in distinguishing diagnostic categories or predicting MCI-to-AD progression. Key biomarkers included alterations in frequency-specific oscillatory activity, functional connectivity patterns, and large-scale network dynamics. Multimodal approaches integrating MEG with structural neuroimaging further improved predictive performance. Discussion/ Despite heterogeneity across study designs, AI-driven MEG analyses hold significant translational potential for early, non-invasive dementia prediction, enhancing diagnostic and prognostic accuracy. Advancing clinical translation will require standardized preprocessing pipelines, larger multicenter cohorts, and explainable AI frameworks. Future research should leverage next-generation MEG technologies, such as optically pumped magnetometers, to capture brain dynamics in ecologically valid, real-world scenarios. Integrating these data with AI-driven multimodal biomarkers will improve individualized risk prediction, early diagnosis, and therapeutic decision-making in dementia.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Chatzidimitriou, E., Styliadis, C., Rankin, K. P., Moraitou, D., Ioannidis, P., & Bamidis, P. D. (2026). AI-driven magnetoencephalography biomarkers in dementia risk prediction: current evidence, challenges and future perspectives. Frontiers in Dementia. https://doi.org/10.3389/frdem.2026.1743627

Vancouver

Chatzidimitriou E, Styliadis C, Rankin KP, Moraitou D, Ioannidis P, Bamidis PD. AI-driven magnetoencephalography biomarkers in dementia risk prediction: current evidence, challenges and future perspectives. Frontiers in Dementia. 2026. doi:10.3389/frdem.2026.1743627. PMID: 42022294.

BibTeX

@article{chatzidimitriou2026-42022294,
  author  = {Chatzidimitriou, Electra and Styliadis, Charis and Rankin, Katherine P. and Moraitou, Despina and Ioannidis, Panagiotis and Bamidis, Panagiotis D.},
  title   = {{AI-driven magnetoencephalography biomarkers in dementia risk prediction: current evidence, challenges and future perspectives}},
  journal = {Frontiers in Dementia},
  year    = {2026},
  doi     = {10.3389/frdem.2026.1743627},
  pmid    = {42022294},
  url     = {https://doi.org/10.3389/frdem.2026.1743627}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Fourteen studies met eligibility criteria, covering populations from healthy controls to individuals with subjective cognitive decline, MCI, AD, and other dementias.
MEG systems varied, with most studies employing 306-channel whole-head systems.
ML algorithms ranged from traditional approaches, such as support vector machines and random forests, to deep learning architectures, including convolutional neural networks.
Reported classification accuracies ranged from moderate (~60%) to high, with several studies achieving over 80% in distinguishing diagnostic categories or predicting MCI-to-AD progression.
Key biomarkers included alterations in frequency-specific oscillatory activity, functional connectivity patterns, and large-scale network dynamics.

Why it matters

This review of fourteen studies found that AI-driven MEG analyses showed classification accuracies ranging from about 60% to over 80% for distinguishing diagnostic categories or predicting MCI-to-AD progression. The authors note heterogeneity across studies and state that standardized pipelines, larger multicenter cohorts, and explainable AI are needed before clinical translation.

New to this subject? Start with our plain-English guide: Getting a diagnosis →

Study details

Evidence strengthLow

How this study scored 39/100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Frontiers in Dementia)
Journal's citation record	0 / 4	Frontiers in Dementia: journal h-index 13 (OpenAlex, 2026-10-29)
Study design	0 / 12	No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence	1 / 5	Rated “low” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	5 / 5	2026 — within 1 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	0 / 3	No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	0 / 2	No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited	1 / 7	Cited 2 times (OpenAlex, 2026-10-10)
Citations per year	1 / 5	1.0 citations a year over 2 year(s) since 2026
Impact for its field and year	4 / 6	Cited 9.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	0 / 6	No other study in this library cites it
Still being cited	0 / 4	Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	3 / 4	Last-listed author Panagiotis D. Bamidis: h-index 50 (OpenAlex, whole career)
Institution's track record	2 / 3	University of California, San Francisco: institution h-index 1,915 (OpenAlex)
Multi-centre collaboration	1 / 3	OpenAlex lists 3 institution(s) in 2 countries
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 42022294)
Free to read	2 / 2	Free to read
Total	39 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis

Also tagged “machine”

835 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →